Investments

Co-Investment
Held / Exited
  • Logo Evergreen
    Co-Investment

    Evergreen

    USA

    Business services
    Business services

    NAIS and Evergreen are two regional industrial cleaning companies, acquired simultaneously, to create a national industrial cleaning platform that offers a one stop shop solution to its customers with best-in-class service quality. The combined entity serves a wide range of end markets including refining, petrochemical, power generation, manufacturing, mining and waste-to-energy. It provides base cleaning services as well as specialty services.

  • WCG logo
    Co-Investment

    WCG

    USA

    Healthcare & life science

    Exited

    Healthcare & life science

    WIRB is the largest US « IRBs » (Institutional Review Boards), which are federally mandated to approve ethical issues in research protocols involving human subjects.

  • Logo Kangji Medical
    Co-Investment

    Kangji Medical

    China

    Internet Software & Services
    Internet Software & Services

    Kangji Medical is a leading Chinese medical device and consumable manufacturer with focus in abdominal minimally invasive surgery. The company offers a comprehensive portfolio of reusable and disposable instruments for laparoscopy, thoracoscopy, gynecology, urology, gastroenterology and ENT specialties.

  • Logo Mirion
    Co-Investment

    Mirion

    USA

    Healthcare & life science

    Exited

    Healthcare & life science

    Mirion-Canberra group is a global provider of radiation detection, measurement, analysis and monitoring products to the nuclear, home security & defence, and medical markets. The group derives most of its revenues from segments where it holds global #1 market positions: radiation monitoring systems, radiochemistry and health physics. It operates 18 industrial sites and employs ~ 2,000 people.

  • Logo Sequens
    Co-Investment

    Seqens

    France

    Industrials
    Industrials

    Seqens is a producer of essential chemicals for use in everyday products. The group is structured across 3 divisions: Pharmaceutical & Cosmetics, Performance Chemicals and Mineral Specialties. Seqens is an industry leader across a wide range of products including aspirin, paracetamol, salicylic acid, para-aminophenol, soda ash, sodium bicarbonate, phenol and oxygenated solvents. It targets a set of five resilient and diversified end-markets including pharma & healthcare, food & feed, cosmetics, flavors & fragrances, home care and environment. Seqens serves 750 customers from 14 industrial sites located in Europe and Asia, and employs ~1,600 people.

  • MultiPlan
    Co-Investment

    MultiPlan

    USA

    Healthcare & life science
    Healthcare & life science

    MultiPlan is the industry’s most comprehensive provider of healthcare cost management solutions in the U.S. With a network of over one million healthcare providers with extensive proprietary analytics, Multiplan generates over $11 billion in medial cost savings on about 40 million claims annually, acting as an intermediary on behalf of those paying for healthcare. In exchange, healthcare providers benefit from directed patient flow and a single point of payment.

The Ardian team brought a deep sector knowledge, which I think allowed them not only to do a terrific job in that due diligence period, but also meant they could work very efficiently within our deal time frame.

Doug Brody KKR Capital Market

Ardian and Arsenal both want our investments to benefit society and by working together in this case we’ve reduced the time it takes to set up a clinical trial by many months, which means new drugs come to market as quickly and safely as possible.

Steve McLean Partner of Arsenal Capital

During the due diligence phase, we identified Ardian as a future shareholder capable of making a significant contribution to Emera's development. As soon as the transaction closed, we were able to define and launch value-creating initiatives with Naxicap and Ardian, particularly in terms of group structuring, external growth, digital transformation and real estate strategy, in France but also in Spain and other European countries.

Eric Baugas CEO of EMERA